MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling

por Zhou, Zheng-Jun, Luo, Chu-Bin, Xin, Hao-Yang, Hu, Zhi-Qiang, Zhu, Gui-Qi, Li, Jia, Zhou, Shao-Lai
Publicado 2020

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection

por Hu, Zhi-Qiang, Zhou, Zheng-Jun, Luo, Chu-Bin, Xin, Hao-Yang, Li, Jia, Yu, Song-Yang, Zhou, Shao-Lai
Publicado 2020

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma

por Zhou, Shao-Lai, Xin, Hao-Yang, Sun, Rong-Qi, Zhou, Zheng-Jun, Hu, Zhi-Qiang, Luo, Chu-Bin, Wang, Peng-Cheng, Li, Jia, Fan, Jia, Zhou, Jian
Publicado 2021

LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2

por Yin, Dan, Hu, Zhi‐Qiang, Luo, Chu‐Bin, Wang, Xiao‐Yi, Xin, Hao‐Yang, Sun, Rong‐Qi, Wang, Peng‐Cheng, Li, Jia, Fan, Jia, Zhou, Zheng‐Jun, Zhou, Jian, Zhou, Shao‐Lai
Publicado 2021

Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma

por Xin, Hao-Yang, Sun, Rong-Qi, Zou, Ji-Xue, Wang, Peng-Cheng, Wang, Jia-Yin, Ye, Yu-Hang, Liu, Kai-Xuan, Hu, Zhi-Qiang, Zhou, Zheng-Jun, Fan, Jia, Zhou, Jian, Zhou, Shao-Lai
Publicado 2023

Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence

por Zhou, Shao-Lai, Zhou, Zheng-Jun, Song, Cheng-Li, Xin, Hao-Yang, Hu, Zhi-Qiang, Luo, Chu-Bin, Luo, Yi-Jie, Li, Jia, Dai, Zhi, Yang, Xin-Rong, Shi, Ying-Hong, Wang, Zheng, Huang, Xiao-Wu, Fan, Jia, Zhou, Jian
Publicado 2022